Filing Details
- Accession Number:
- 0001236031-19-000031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-10-28 06:32:42
- Reporting Period:
- 2019-10-25
- Accepted Time:
- 2019-10-28 06:32:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 725363 | Cel Sci Corp | CVM | Biological Products, (No Disgnostic Substances) (2836) | 840916344 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236030 | R Geert Kersten | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-10-25 | 3,725 | $6.71 | 1,107,424 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- On October 25, 2019, Mr. Kersten purchased $25,000 worth of restricted stock directly from the Company at the closing price on October 24, 2019, the most recent closing price available.
Billionaire Hedge Funds
